Company Filing History:
Years Active: 2013
Title: Min Li - Innovator in Synthetic Peptides
Introduction
Min Li is a notable inventor based in Forest Park, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides. His work focuses on enhancing tight junction permeability, which has important implications for medical treatments.
Latest Patents
Min Li holds a patent for "Synthetic peptides that enhance tight junction permeability." This invention provides novel peptides that facilitate the opening of mammalian tight junctions, known as tight junction agonists. The patent also outlines methods for treating diseases by administering a composition that includes a peptide tight junction agonist in combination with a therapeutically effective amount of an active agent. This innovative approach has the potential to improve therapeutic outcomes for various medical conditions.
Career Highlights
Min Li is currently associated with Alba Therapeutics Corporation, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of tight junctions in drug delivery and disease treatment. With a focus on practical applications, Min Li's contributions are paving the way for new therapeutic strategies.
Collaborations
Min Li collaborates with Amir P Tamiz, leveraging their combined expertise to further enhance the impact of their research. Their partnership exemplifies the collaborative spirit that drives innovation in the biotechnology sector.
Conclusion
Min Li's work in synthetic peptides represents a significant advancement in the field of biotechnology. His innovative patent and ongoing research at Alba Therapeutics Corporation highlight his commitment to improving medical treatments through scientific innovation.